Effects of Breast Intervention During the Late Pregnancy on the Parturients' Breast Engorgement,Maternal Competence,and Stress
Launched by NATIONAL DEFENSE MEDICAL CENTER, TAIWAN · Mar 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special treatment for breast tenderness can help pregnant women during the later stages of their pregnancy. The goal is to see if this intervention can reduce breast engorgement (which is when the breasts become overly full and uncomfortable), improve breastfeeding, increase mothers' confidence in caring for their babies, and lower stress levels.
To be part of this study, women need to be healthy, over 20 years old, and at least 36 weeks pregnant. They should be able to read or communicate in Chinese or Taiwanese and agree to participate after being fully informed about the trial. Women with a history of substance abuse, certain health complications, or who are unable to breastfeed will not be included in the study. Participants can expect to receive support and care during the trial, and their experiences will help researchers learn more about the benefits of this intervention for new mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy pregnant women over 20 years old, without mental illness, and the number of pregnancy weeks has reached 36 weeks; 2. Full term production; 3. Literate or able to communicate in Chinese and Taiwanese; 4. After explaining, agree to participate in the research, sign the consent form, and accept long-term follower
- Exclusion Criteria:
- • 1. Pregnant women with a history of smoking, alcohol, and drug abuse;
- • 2. Pregnant women have mental illness;
- • 3. Maternal complications during childbirth or postpartum, such as: postpartum hemorrhage, infection, etc.;
- • 4. Newborns with congenital abnormalities and major diseases;
- • 5. Pregnant women who are unable or unwilling to breastfeed due to illness or other factors;
- • 6. Refuse to accept breast compression intervention will be excluded from participating in the study
About National Defense Medical Center, Taiwan
The National Defense Medical Center (NDMC) in Taiwan is a premier institution dedicated to advancing military and civilian healthcare through innovative research and clinical trials. As a leading sponsor of clinical studies, NDMC focuses on enhancing medical care for armed forces personnel and the general population by investigating new treatments and therapies. The center fosters collaboration among healthcare professionals, researchers, and military experts to address pressing health issues and improve patient outcomes. With a commitment to ethical standards and scientific excellence, NDMC plays a pivotal role in shaping the future of medical advancements in Taiwan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials